Tag: Coronavirus information (COVID-19)
Press Releases
Sinovac Signs Agreement with Bio Farma Indonesia for COVID-19 Vaccine Cooperation
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced it has signed two agreements in Hainan, China with PT Bio Farma,...
News
AstraZeneca begins Phase III trial of Covid-19 vaccine in US
AstraZeneca has expanded the clinical development of its potential Covid-19 vaccine candidate AZD1222 in the US, by initiating a Phase 3 clinical trial, dubbed...
News
Sanofi provides update on Kevzara Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S.
Sanofi announced that the global Phase 3 trial investigating intravenously administered Kevzara® (sarilumab) at a dose of 200 mg or 400 mga in severely...
Press Releases
Avacta Expands Rapid SARS-CoV-2 Antigen Test Manufacturing Capacity
Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into an agreement with Abingdon Health...
News
Gilead’s Investigational Antiviral Veklury Receives U.S. FDA Emergency Use Authorization for the Treatment of Patients With Moderate COVID-19
Gilead Sciences, Inc. announced the U.S. FDA expanded the EUA enabling use of the investigational antiviral Veklury® (remdesivir) to treat all hospitalized patients with...
News
Novavax to Supply 76M Doses of COVID-19 Vax to Canada
Novavax, Inc. has reached an agreement in principle with the Government of Canada to supply up to 76 million doses of NVX-CoV2373, Novavax’ COVID-19...
News
FDA Clears SPI’s Ebselen for Phase II COVID-19 Trials
Sound Pharmaceuticals, Inc. (SPI) received clearance from the FDA to begin two Phase 2 studies of ebselen (SPI-1005) in COVID-19 patients. SPI-1005 is a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read